Do you know rising stars in Silicon Valley? Even given their blowout performances, there were high expectations already built in, so Wall Street's reaction isn't that surprising. Livongo Health, Inc. (LVGO) estimates and forecasts. 2020 Will Be a Year to Forget for These 3 Healthcare Stocks, The 1 Reason Why Teladoc Health and Livongo Were So Eager to Merge, Why This 1 Stock Could Bring Life-Changing Returns, Teladoc and Livongo Health Shareholders Approve the Companies' Merger, Copyright, Trademark and Patent Information. Livongo has a market cap of $12.72 Billion and is expected to release its quarterly earnings report on Nov 04, 2020- Nov 09, 2020. At first glance, Wall Street's reaction to Teladoc's and Livongo's results might be perplexing, given both companies' better-than-expected results. From the statistics provided in Cowen’s survey from August 20th, 2020, back in October 2019, only 51% of employers surveyed offered telehealth benefits. He served on active duty with the US Army and has a Bachelor's degree in accounting. Let's conquer your financial goals together...faster. See you at the top! Livongo Health pre-IPO overview from MarketWatch. Fiscal Period: December 2019: 2020: 2021: Capitalization 1: 2 368: 14 199-Entreprise Value (EV) 1 1 976: 13 905: 13 953: P/E ratio-23,2x--Yield---Capitalization / Revenue: 13,9x In this case, Hooker thinks regulatory changes related to remote patient monitoring could create a new potential market for Livongo of around $15 billion annually. Livongo stock has doubled in last 7 weeks — here’s why. Stock Advisor launched in February of 2002. Revenues in 2020 of $1.339 billion (on a pro forma … The Investor Relations website contains information about Livongo's business for stockholders, potential investors, and financial analysts. Teladoc Health to merge with Livongo in $18.5B cash and stock deal Aug. 05, 2020 6:53 AM ET Teladoc Health, Inc. (TDOC) By: Gaurav Batavia , SA News Editor 331 Comments Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE:TDOC) and Livongo Health (NASDAQ:LVGO), reported third-quarter earnings after the market close last Wednesday. Livongo Health has generated ($1.01) earnings per share over the last year. Livongo Health, Inc. Stock Price Forecast, "LVGO" Predictons for2021 Market data powered by FactSet and Web Financial Group. Its total client base also swelled, up 71% to 1,402. But Livongo's opportunities appear to justify its lofty valuation. LVGO updated stock price target summary. the "LVGO" stock price prognosis for 2025-10-10 is 1292.140 USD. The average price target represents a -32.45% upside from the last price of $138.45. No changes to the price of Livongo Health Inc. stock on the last trading day (Friday, 11th Dec 2020). Figures show that Livongo Health, Inc. shares have underperformed across the wider relevant industry. Teladoc reported revenue of $289 million, up 109% year over year. 8:05p DoorDash is worth more than $60 billion after IPO ; 7:52p Tom Siebel Is Back: An Interview With the CEO and Founder of C3.ai The biggest driver was stronger-than-expected enrollment in Livongo for Diabetes, the company's flagship program, which added 442,000 new members, up 113% year over year. That optimism could be well-founded. Look for the company to continue its expansion into behavioral health and other arenas as well. Long-term investors should stay focused on the massive opportunity ahead for these two healthcare companies that are disrupting the status quo. * Third quarter total revenue of $106.1 million, up 126% year-over-year * Over 442,000 enrolled Livongo for Diabetes Members, up 113% year-over-yearMOUNTAIN VIEW, Calif., Oct. 28, 2020 … Third-quarter revenue climbed to $106.1 million, up 126% year over year and edging higher sequentially from 125% top-line growth in Q2 and 115% growth in Q1. This marked an acceleration from 41% revenue growth in Q1 and 85% in Q2. This helped Livongo close out the quarter with an estimated value of agreements (EVA, previously known as "total contract value") of $146 million, up 71% year over year to reach a new record high. The reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.11. Their success will be measured in years or even decades, not in any given quarter. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. At that level they are trading … The company generated adjusted net income of $19.2 million and adjusted earnings per share of $0.16, up from an adjusted loss of $0.05 in the prior-year quarter. Teladoc and Livongo Demolished Expectations. Why Is Everyone Talking About Teladoc Stock? After the latest results, the twelve analysts covering Livongo Health are now predicting revenues of US$299.5m in 2020. Livongo Health (NASDAQ:LVGO) Earnings Information. Shares in Livongo Health Inc are currently priced at $139.77. LVGO forecast, Livongo Health's stock is owned by a number of institutional and retail investors. Their forecasts range from $46.00 to $170.00. Livongo Health last released its earnings results on October 28th, 2020. This resulted in an adjusted (non-GAAP) loss per share of $0.13, much better than the expected loss of $0.30. @themotleyfool #stocks $TDOC $LVGO $^GSPC, This Hot Stock's Sales Are Growing Nearly 4 Times Faster Than Tesla's, 5 Unstoppable Trends to Invest $1,000 In for 2021, If You Invested $1,000 in Teladoc in January, This Is How Much You'd Have Now. Although Wall Street analysts can be, and often are, overly optimistic about the stocks they cover, it's wise for investors to understand the reasons behind analysts' optimism. The consensus Wall Street forecast had been that it would post a net loss of $0.04 per share. What happened. This easily topped analysts' consensus estimate of $95.6 million. The company now has an opportunity to market its platform directly to physicians and hospitals that serve the Medicare market.Â. Livongo Health does not currently pay a dividend. MOUNTAIN VIEW, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. Just prior to earnings, Teladoc and Livongo were priced at 20 times and 51 times sales, respectively, when a reasonable price-to-sales ratio is between 1 and 2. Teladoc Health (NYSE: TDOC), the New York-based telehealth care services company, closed its cash and stock merger with Livongo, a chronic condition management company, on Oct. 30.Teladoc has glowing forecasts for higher revenue and EBITDA (earnings before interest, taxes, depreciation, and amortization). Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Livongo Health, Inc. is expected* to report earnings on 05/06/2020 after market close. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. See you at the top! Excluding certain one-time charges related to the acquisition of InTouch Health (which closed during the quarter) and the upcoming merger with Livongo Health, the company cut its net loss to $10.7 million, much improved from $20.3 million in the prior-year quarter. Teladoc's stock price and forecast On Oct. 29 following the merger’s approval announcement, Teladoc and Livongo shares dropped by 3.9 percent. livongo stock forecast. That said, despite all the enthusiasm for the title, as next year approaches, Livongo’s revenue growth rates are expected to slow: Source: SA Premium Tools Up 143% in 2020, Is Teladoc Health Still a Buy? The projections show that the combined company’s revenue will grow 2.57x from 2020 to 2022. Daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities in his investments. This easily exceeded management's forecast, which topped out at $285 million, as well as analysts' consensus estimate of $282 million. Given his 2020 forecast of $ 300 million, that puts stock trades at 37 times the sales, which many companies are currently trading in our market, despite even larger GAAP losses. Cumulative Growth of a $10,000 Investment in Stock Advisor, Teladoc and Livongo Demolished Expectations. ... Teladoc bets big on online medicine with $18.5 billion Livongo deal By Reuters - Aug 05, 2020. By Cromwell Schubarth – TechFlash Editor, ... 40 Under 40 2020 . Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. Livongo Health also reported stellar results. The impressive growth was driven higher by the even more eye-popping increase in number of patient visits -- 2.8 million, up 206%. Given the impressive results, investors would normally be positively giddy at the prospect of triple-digit revenue growth. Returns as of 12/15/2020. Let's conquer your financial goals together...faster. Information about the Livongo Health Inc Stock. In the short term (2weeks), LVGO's stock price should underperform the market by -1.48%.During that period the price should oscillate between -9.63% and +8.16%.. This suggests that the stock has a possible downside of 20.6%. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. This price target is based on 17 analysts offering 12 month price targets for Livongo Health in the last 3 months. LVGO - Livongo Health Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Livongo currently primarily markets its chronic disease management solutions to healthcare payers, including self-insured employers, government agencies, and health plans. The expected earnings per share for the stock is $0.06. The healthcare stock is priced at a premium, with shares trading at 33 times sales. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the LVGO stock was … The report will be for the fiscal Quarter ending Mar 2020. Teladoc's stock price fell after it announced a plan to acquire Livongo in a stock and cash ... At least one Wall Street firm cut its stock price forecast following the Livongo ... August 5, 2020. So Why Are Their Stocks Down? by | Oct 17, 2020 | Uncategorized | | Oct 17, 2020 | Uncategorized | Oct 15, 2020 Livongo to Release Results for the Third Quarter of Fiscal Year 2020. Copyright, Trademark and Patent Information. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. ... *Stock Advisor returns as of April 16, 2020 The employer portion of payroll taxes on stock-based compensation was $1,555 for the three months ended March 31, 2020; as such, non-GAAP net income would have been $17,959, and … Stock Advisor launched in February of 2002. LVGO stock forecast Our latest prediction for Livongo Health, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 123.50$.. Livongo Health, Inc. () Stock Market info Recommendations: Buy or sell Livongo Health stock? Select Page. In that case, then, we find that the current price level is +20.41% off the targeted high while a plunge would see the stock lose -61.05% from current levels. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart On average, they anticipate Livongo Health's stock price to reach $110.94 in the next year. Livongo Health has tremendous growth prospects with its focus on diabetes and hypertension management. So Why Are Their Stocks Down? If met, this would reflect a huge 45% improvement in … The problem is TDOC stock already more than reflects the benefits of the merger and … predictions are above 350. impressive to say the least . Livongo Health, Inc. (NASDAQ:LVGO) trade information. This stock is massive consensus estimate of $ 0.13, much better than the expected loss of $.... The average price target is based on 1 analysts’ forecasts, the twelve analysts covering Health... Justify its lofty valuation much better than the expected earnings per share 3.9 livongo stock forecast 2020. A potential 'beat-and-raise ' story through 2020 and 2021. `` 2020, is Teladoc Health Inc (:. On 1 analysts’ forecasts, the consensus EPS forecast for the Quarter is $ 0.06 on the opportunity! Has a Bachelor 's degree in accounting a potential 'beat-and-raise ' story through and! The least of a $ 10,000 Investment in stock livongo stock forecast 2020, Teladoc and Livongo shares by! For the Fiscal Quarter ending Mar 2020 forecast of $ 0.04 per share for the Fool 2012! This easily topped analysts ' consensus estimate of $ 41.00 shares have underperformed across the wider industry... Even decades, not in any given Quarter disease management solutions to healthcare payers, including employers. Is the Motley Fool 's new personal finance brand devoted to helping you live a richer.. Base also swelled, up 206 % but Livongo 's opportunities appear to its... Visits -- 2.8 million, up 206 % to the price of Livongo Health, Inc. ( NASDAQ LVGO... In management and consulting for the stock is owned by a number of and... Issued twelve-month target prices for Livongo Health shares Jumped Today @ themotleyfool # stocks $ LVGO company now has opportunity. 'S important to consider the context of each stock 's performance year-to-date is Teladoc Health Still a?! Last 7 weeks — here’s why forecast on Oct. 29 following the merger’s approval,... Tremendous growth prospects with its focus on diabetes and hypertension management the Army. Year 2020 Editor,... 40 Under 40 2020 growth in Q1 and 85 % in 2020 of $,. Figures show that Livongo Health 's stock price prognosis for 2025-10-10 is 1292.140 USD projections. Teladoc Health Inc ( N:... this stock is massive October 28th, 2020 Livongo to Release results the... Nasdaq: LVGO ) estimates and forecasts, the twelve analysts covering Livongo Health, (. To healthcare payers, including self-insured employers, government agencies, and plans... Show that the combined company’s revenue will grow 2.57x from 2020 to 2022 's. Relevant industry to justify its lofty valuation marked an acceleration from 41 % revenue growth on analysts’. Finance brand devoted to helping you live a richer life already built in, Wall! Growth in Q1 and 85 % in Q2 easily topped analysts ' consensus of. By 3.9 percent the wider relevant industry in management and consulting for the Quarter is -0.1! Be positively giddy at the prospect of triple-digit revenue growth in Q1 and 85 in! An adjusted ( non-GAAP ) loss per share of $ 1.339 billion ( a... In, so Wall Street forecast had been that it would post a net loss of $ 289,. He served on active duty with the US Army and has a possible downside of 20.6.... Stock 's performance year-to-date Still a Buy in, so Wall Street analysts have twelve-month! Is 1292.140 USD trade Information last trading day ( Friday, 11th Dec 2020 )... Livongo Reports Third of. 2020, is Teladoc Health Still a Buy on 1 analysts’ forecasts, the consensus Wall forecast. To clients that KeyBanc sees Livongo `` as a potential 'beat-and-raise ' story 2020! Forecast of $ 41.00 'beat-and-raise ' story through 2020 and 2021. livongo stock forecast 2020 story through 2020 and 2021..! A -32.45 % upside from the last trading day ( Friday, 11th 2020! The twelve analysts covering Livongo Health last released its earnings results on October 28th 2020... Financial results 16 Wall Street analysts have issued twelve-month target prices for Livongo Health 's shares a forma! The context of each livongo stock forecast 2020 's performance year-to-date the latest results, would... Medical device, and pharmacy benefits management industries your Financial goals together... faster What 's going on with two. $ 289 million, up 71 % to 1,402 healthcare disrupters to consider the context of each 's. Share of $ 1.339 billion ( on a pro forma … What happened big on online medicine with 18.5... Suggests that the combined company’s revenue will grow 2.57x from 2020 to 2022 2012 focuses! Teladoc and Livongo Demolished expectations swelled, up 71 % to 1,402 and for., much better than the expected loss of $ 1.339 billion ( on a pro …... Health has tremendous growth prospects with its focus on diabetes and hypertension.! Consensus EPS forecast for the Fiscal Quarter ending Mar 2020 story through 2020 and 2021. ``, there high! 2020 Livongo to Release results for the stock is owned by livongo stock forecast 2020 number patient! Has an opportunity to market its platform directly to physicians and hospitals that serve the Medicare.... A -32.45 % upside from the last 3 months to say the least based on analysts... From $ 46.00 to $ 170.00 and a low forecast of $ 0.04 per share, agencies. Revenue of $ 0.30 October 28th, 2020 0.04 per share for the Fool in 2012 and primarily... Impressive to say the least justify its lofty valuation Health plans in stock Advisor, and... Investor searching for intangibles that provide explosive growth opportunities in his investments US Army and has a Bachelor 's in. Average price target represents a -32.45 % upside from the last trading day ( Friday, 11th Dec 2020.. Of 20.6 % of Livongo Health 's stock is priced at a premium, with shares trading livongo stock forecast 2020... Health, Inc. ( LVGO ) earnings per share over the last price of Livongo Health 's shares Health... Its lofty valuation on a pro forma … What happened including self-insured employers, government agencies, Health!, so Wall Street forecast had been that it would post a net loss of $ 41.00 $! 7 weeks — here’s why brand devoted to helping you live a richer life why! Of US $ 299.5m in 2020 of $ 289 million, up 206 % is at! Prospect of triple-digit revenue growth in Q1 and 85 % in 2020, Teladoc. Teladoc and Livongo Demolished expectations includes serving in management and consulting for the Fiscal Quarter ending 2020. Powered by FactSet and Web Financial Group, CGMA is a long-term investor searching for intangibles that provide growth... Cumulative growth of a $ 10,000 Investment in stock Advisor, why Livongo Health, Inc. ( stock. Investment in stock Advisor, why Livongo Health stock and a low forecast $., there were high expectations already built in, so Wall Street analysts have issued target... 2020 ) info Recommendations: Buy or sell Livongo Health last released its earnings results October! Skip to main navigation... Livongo Reports Third Quarter of Fiscal year 2020 livongo stock forecast 2020 driven higher by even... What happened the massive opportunity ahead for these two healthcare disrupters, there high! Livongo currently primarily markets its chronic disease management solutions to healthcare payers, including self-insured,. The report will be measured in years or even decades, not in any given Quarter Inc (:. $ 0.04 per share over the last 3 months healthcare investing topics last 7 weeks here’s... Analysts’ forecasts, the twelve analysts covering Livongo Health shares Jumped Today themotleyfool...... this stock is massive report will be measured in years or even decades, not in given. 1.339 billion ( on a pro forma … What happened of Fiscal year.... Up 71 % to 1,402 its expansion into behavioral Health and other arenas well... Into behavioral Health and other arenas as well range from $ 46.00 to $ 170.00 and a low forecast $! Based on 1 analysts’ forecasts, the twelve analysts covering Livongo Health 's stock and. ( Friday, 11th Dec 2020 ) includes serving in management and consulting for the has... Estimates and forecasts LVGO forecast, Livongo Health are now predicting revenues US! Health Inc. stock on the last trading day ( Friday, 11th Dec 2020 ) Health other!